MeVis Medical Solutions AG reported consolidated earnings results for the second quarter and first half of 2013. For the quarter, the company reported that sales exceeded the prior-year quarter with EUR 3,544,000 by 9 % against EUR 3,241,000 a year ago.

For the period, the company reported sales of EUR 6,862,000 against EUR 6,878,000 a year ago. EBIT (earnings before interest and taxes) was EUR 1,638,000 up a significant 30% on the prior-year figure of EUR 1,256,000, mainly due to a consistent cost management. Consolidated net profit was EUR 1,551,000 against EUR 666,000. Earnings per share were EUR 0.90 against EUR 0.39 a year ago.

The company provided earnings guidance for the fiscal year 2013. The company said that for year 2013 consolidated revenues are now expected to remain stable compared to the previous year. For the EBIT, an increase over the previous year is now expected, whereby the decline of the capitalization of development costs should be offset by the cost reductions achieved (previous forecast: slight decline of the EBIT). Overall for 2013, the company now expects a positive cash flow.